These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11451573)
1. Inhibin binding sites and proteins in pituitary, gonadal, adrenal and bone cells. Farnworth PG; Harrison CA; Leembruggen P; Chan KL; Stanton PG; Ooi GT; Rahman NA; Huhtaniemi IT; Findlay JK; Robertson DM Mol Cell Endocrinol; 2001 Jun; 180(1-2):63-71. PubMed ID: 11451573 [TBL] [Abstract][Full Text] [Related]
2. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Chapman SC; Bernard DJ; Jelen J; Woodruff TK Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827 [TBL] [Abstract][Full Text] [Related]
3. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726 [TBL] [Abstract][Full Text] [Related]
4. Identification of specific inhibin A-binding proteins on mouse Leydig (TM3) and sertoli (TM4) cell lines. Harrison CA; Farnworth PG; Chan KL; Stanton PG; Ooi GT; Findlay JK; Robertson DM Endocrinology; 2001 Apr; 142(4):1393-402. PubMed ID: 11250918 [TBL] [Abstract][Full Text] [Related]
5. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Ethier JF; Farnworth PG; Findlay JK; Ooi GT Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797 [TBL] [Abstract][Full Text] [Related]
8. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Bernard DJ; Chapman SC; Woodruff TK Mol Endocrinol; 2002 Feb; 16(2):207-12. PubMed ID: 11818494 [TBL] [Abstract][Full Text] [Related]
9. Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo. Makanji Y; Temple-Smith PD; Walton KL; Harrison CA; Robertson DM Endocrinology; 2009 Oct; 150(10):4784-93. PubMed ID: 19589860 [TBL] [Abstract][Full Text] [Related]
10. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin. Chapman SC; Woodruff TK Endocrinology; 2003 Dec; 144(12):5640-9. PubMed ID: 14500575 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes. Ramasharma K; Li CH Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3595-8. PubMed ID: 3035540 [TBL] [Abstract][Full Text] [Related]
12. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor. Bernard DJ; Smith CL; Brûlé E Trends Endocrinol Metab; 2020 Jan; 31(1):37-45. PubMed ID: 31648935 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan. Gray PC; Bilezikjian LM; Vale W Mol Cell Endocrinol; 2001 Jun; 180(1-2):47-53. PubMed ID: 11451571 [TBL] [Abstract][Full Text] [Related]
14. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. Cheifetz S; Ling N; Guillemin R; Massagué J J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159 [TBL] [Abstract][Full Text] [Related]
15. Identification of high affinity binding sites for inhibin on ovine pituitary cells in culture. Hertan R; Farnworth PG; Fitzsimmons KL; Robertson DM Endocrinology; 1999 Jan; 140(1):6-12. PubMed ID: 9886800 [TBL] [Abstract][Full Text] [Related]
16. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Vänttinen T; Liu J; Kuulasmaa T; Kivinen P; Voutilainen R J Endocrinol; 2003 Sep; 178(3):479-89. PubMed ID: 12967339 [TBL] [Abstract][Full Text] [Related]
17. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Bilezikjian LM; Vaughan JM; Vale WW Endocrinology; 1993 Dec; 133(6):2545-53. PubMed ID: 8243276 [TBL] [Abstract][Full Text] [Related]
18. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle. Lovell TM; Knight PG; Gladwell RT J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664 [TBL] [Abstract][Full Text] [Related]
19. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. Vänttinen T; Kuulasmaa T; Liu J; Voutilainen R J Clin Endocrinol Metab; 2002 Sep; 87(9):4257-63. PubMed ID: 12213882 [TBL] [Abstract][Full Text] [Related]
20. Inhibin is an antagonist of bone morphogenetic protein signaling. Wiater E; Vale W J Biol Chem; 2003 Mar; 278(10):7934-41. PubMed ID: 12493742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]